RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $462,237 | +34.1% | 20,163 | -3.6% | 0.00% | – |
| Q2 2023 | $344,740 | +54.4% | 20,906 | +7.8% | 0.00% | – |
| Q1 2022 | $223,315 | -9.2% | 19,385 | -21.5% | 0.00% | – |
| Q4 2021 | $246,000 | -22.9% | 24,695 | +1.1% | 0.00% | – |
| Q3 2021 | $319,000 | -36.6% | 24,423 | -5.0% | 0.00% | – |
| Q2 2021 | $503,000 | +7.5% | 25,708 | +16.7% | 0.00% | – |
| Q1 2021 | $468,000 | -22.4% | 22,022 | +8.5% | 0.00% | -100.0% |
| Q4 2020 | $603,000 | +39.6% | 20,294 | +1.9% | 0.00% | – |
| Q3 2020 | $432,000 | -2.7% | 19,925 | -2.1% | 0.00% | – |
| Q2 2020 | $444,000 | +51.5% | 20,362 | +5.9% | 0.00% | – |
| Q1 2020 | $293,000 | -11.7% | 19,228 | +33.1% | 0.00% | – |
| Q4 2019 | $332,000 | +4.1% | 14,451 | -4.1% | 0.00% | – |
| Q3 2019 | $319,000 | -3.9% | 15,076 | -0.2% | 0.00% | – |
| Q2 2019 | $332,000 | +5.7% | 15,106 | +50.8% | 0.00% | – |
| Q2 2018 | $314,000 | +116.6% | 10,017 | +37.8% | 0.00% | – |
| Q1 2018 | $145,000 | -21.2% | 7,268 | +15.0% | 0.00% | – |
| Q4 2017 | $184,000 | – | 6,318 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |